Middlebrook Pharma adds 271 reps

Westlake, Texas-based MiddleBrook Pharmaceuticals, Inc. has completed the hiring of its 271-person nationwide field sales force. The 271 territory managers comprising MiddleBrook's field sales force will begin educating healthcare professionals on the benefits of Moxatag (extended-release amoxicillin) tablets, 775 mg—a once-daily amoxicillin that was approved by the FDA on Jan. 23, 2009.

According to Middlebrook officials, MiddleBrook's territories have been structured to maximize the 271-person field sales force's ability to detail healthcare professionals nationwide, including pharmacists. The field force's efforts will be supported by a print media campaign targeted at healthcare professionals. 

John Thievon, president and CEO of MiddleBrook  said, “MiddleBrook's field sales force will be talking to physicians and pharmacists across the country about the benefits of Moxatag, patient convenience, improved compliance and a lower overall daily dose.”
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


Investment in healthcare IT stands at an all-time high. The government has spent billions to promote EHR adoption. Yet the physician wish list is a mile long, while hospitals and patients are not where they need to be. To peel back the layers of what we've all been waiting for in the Great Data Capture of the 21st Century, and to review the changes enabling the healthcare data ecosystem to coexist, MM&M presents this e-Book. Click here.


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.